METHCATHINONE

Important information regarding METHCATHINONE drug use.


Methcathinone is one of the more recent drugs of abuse in the United States and was placed into Schedule I of the CSA in 1993. Known on the streets as "Cat," it is a structural analogue of methamphetamine and cathinone. Clandestinely manufactured, methcathinone is almost exclusively sold in the stable and highly water soluble hydrochloride salt form. It is most commonly snorted, although it can be taken orally by mixing it with a beverage or diluted in water and injected intravenously.

Methcathinone has an abuse potential equivalent to methamphetamine, and produces amphetamine-like activity including superabundant energy, hyperactivity, extended wakefulness and loss of appetite. Pleasant effects include a burst of energy, speeding of the mind, increased feelings of invincibility and euphoria. Unpleasant effects include anxiety, tremor, insomnia, weight loss, dehydration, sweating, stomach pains, pounding heart, nose bleeds and body aches. Toxic levels may produce convulsions, paranoia, and hallucinations. Like other CNS stimulants, binges are usually followed by a "crash" with periods of variable depression.

KHAT For centuries, khat, the fresh young leaves of the Catha edulis shrub, have been consumed where the plant is cultivated, primarily in East Africa and the Arabian peninsula. There, chewing khat predates the use of coffee and is used in a similar social context. Chewed in moderation, khat alleviates fatigue and reduces appetite. Compulsive use may result in manic behavior with grandiose delusions or in a paranoid type of illness, sometimes accompanied by hallucinations.

Khat has been brought into the United States and other countries for use by emigrants from the source countries. It contains a number of chemicals among which are two controlled substances, cathinone (Schedule I) and cathine (Schedule IV). As the leaves mature or dry, cathinone is converted to cathine, which significantly reduces its stimulatory properties.

[Abstracted from D.E.A. website q.v.]





Home
Services
Why Test
Drugs of Abuse
Employer References
MRO Resources
Collection Services
Resources
Rapid Drug Test
Online Training
News Archive
About Us

CONTACT US

Request Information »

Nationwide Medical Review

7168 Graham Road, Suite 150
Indianapolis, IN 46250

Phone 317-547-8620
Toll Free 888-265-6362
Fax 317-568-0849
info@drugfreeworkplace.com

© Copyright 1999 - 2012 Nationwide Medical Review. Website Developed by Elixir Marketing, LLC

Industry News

10-21-2011 Nationwide Medical Review offers NEW! DOT Collector Training Course:

08/16/2010 DOT Issues Final Rule amending certain provisions of its drug testing procedures.

August 31 - Mandated Direct Observation Collection (Return-to-Duty and Follow-up)

 DOT Direct Observation Procedure Sheet 

Self Assessment Quiz!
(Updated 8/09)

For More News
See our Archive